These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18948893)

  • 1. MicroRNA-10b and breast cancer metastasis.
    Gee HE; Camps C; Buffa FM; Colella S; Sheldon H; Gleadle JM; Ragoussis J; Harris AL
    Nature; 2008 Oct; 455(7216):E8-9; author reply E9. PubMed ID: 18948893
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.
    Wang L; Wang J
    Oncogene; 2012 May; 31(20):2499-511. PubMed ID: 21963843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer bone metastasis: molecular basis of tissue tropism.
    Kang Y
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of microRNAs in breast cancer.
    Adams BD; Guttilla IK; White BA
    Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micromanagers of malignancy: role of microRNAs in regulating metastasis.
    Ma L; Weinberg RA
    Trends Genet; 2008 Sep; 24(9):448-56. PubMed ID: 18674843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new path to the cancer epigenome.
    Richon VM
    Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.
    Wang F; Zheng Z; Guo J; Ding X
    Gynecol Oncol; 2010 Dec; 119(3):586-93. PubMed ID: 20801493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
    Kominsky SL; Davidson NE
    J Clin Oncol; 2006 May; 24(15):2227-9. PubMed ID: 16636338
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy.
    Andreopoulou E; Hortobagyi GN
    J Clin Oncol; 2008 Aug; 26(22):3660-2. PubMed ID: 18669447
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer: micromanagement of metastasis.
    Steeg PS
    Nature; 2007 Oct; 449(7163):671-3. PubMed ID: 17928850
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and validation of gene expression profile signatures in early-stage breast cancer.
    Desmedt C; Sotiriou C; Piccart-Gebhart MJ
    Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
    [No Abstract]   [Full Text] [Related]  

  • 16. Micromanaging metastasis.
    Schuldt A
    Nat Cell Biol; 2007 Oct; 9(10):1121. PubMed ID: 17909523
    [No Abstract]   [Full Text] [Related]  

  • 17. Lineage infidelity and expression of melanocytic markers in human breast cancer.
    Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
    Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of metallothionein predicts chemoresistance in breast cancer.
    Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
    J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.